BEVATAS 100 INJECTION

BEVATAS 100 INJECTION is a recombinant monoclonal antibody that belongs to the immunotherapy class of cancer treatment. It can either be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.

While for women with reproductive potential subjected to BEVATAS 100 INJECTION, it is advised to discuss with your doctor regarding effective birth control methods during the treatment. Also to be continued for a minimum of 6 months after the treatment course completion as this medicine may impair fertility.

BEVATAS 100 INJECTION is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28 days before or after surgery.

All the side effects that are relatively caused by BEVATAS 100 INJECTION occur until the drug concentration stays in the body. It is found that this medicine will be contained in our body for almost 4 months after the final dose.

BEVATAS 100 INJECTION is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age. The first dose will be administered for 90 minutes and if well tolerated the infusion time can be reduced to 30 minutes.

Inform your physician before starting your treatment with BEVATAS 100 INJECTION in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.

It is important to inform your doctor about all the medications you are currently taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements, as they may interact with BEVATAS 100 INJECTION.

It is vital to inform your physician before taking BEVATAS 100 INJECTION if you have conditions involving inflammation in the stomach (ulcer, colitis), experience allergic reactions to BEVATAS 100 INJECTION or its ingredients, have recently undergone surgery (due to the risk of bleeding), or have diabetes, hypertension, or heart problems.

BEVATAS 100 INJECTION is made using the molecule called BEVACIZUMAB.

BEVATAS 100 INJECTION is prescribed for anti-cancer treatment.